Cargando…

Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities

Toll-like receptors (TLRs) are indispensable for the activation, maintenance and halting of immune responses. TLRs can mediate inflammation by recognizing molecular patterns in microbes (pathogen-associated molecular patterns: PAMPs) and endogenous ligands (danger-associated molecular patterns: DAMP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haroun, Ryma, Naasri, Sahar, Oweida, Ayman J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10146579/ https://www.ncbi.nlm.nih.gov/pubmed/37112730 http://dx.doi.org/10.3390/vaccines11040818

Ejemplares similares

Combination of CAR‑T cell therapy and radiotherapy: Opportunities and challenges in solid tumors (Review)
por: Zhong, Liqiang, et al.
Publicado: (2023)

Toll-Like Receptor Signaling Pathways—Therapeutic Opportunities
por: Zhu, Jiankun, et al.
Publicado: (2010)

Toll-Like Receptor 3 in Solid Cancer and Therapy Resistance
por: Muresan, Ximena Maria, et al.
Publicado: (2020)

CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021)

Chimeric-antigen receptor T (CAR-T) cell therapy for solid tumors: challenges and opportunities
por: Xia, An-Liang, et al.
Publicado: (2017)

Expression of Toll-Like Receptors on Breast Tumors: Taking a Toll on Tumor Microenvironment
por: Bhattacharya, Debika, et al.
Publicado: (2012)

Toll-like receptors and toll-like receptor-targeted immunotherapy against glioma
por: Xun, Yang, et al.
Publicado: (2021)

Toll-Like Receptors (TLRs): The Role in Tumor Progression
por: Shcheblyakov, D.V., et al.
Publicado: (2010)

The role of toll-like receptor 4 in tumor microenvironment
por: Li, Jing, et al.
Publicado: (2017)

Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
por: Yang, Yang, et al.
Publicado: (2022)

Toll-Like Receptors in Atherosclerosis
por: Falck-Hansen, Mika, et al.
Publicado: (2013)

Toll-like Receptors and Thrombopoiesis
por: Tang, Xiaoqin, et al.
Publicado: (2023)

Toll-like receptors and their role in carcinogenesis and anti-tumor treatment
por: Wolska, Anna, et al.
Publicado: (2008)

The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
por: Huang, Lingling, et al.
Publicado: (2022)

Immunotherapeutic Implications of Toll-like Receptors Activation in Tumor Microenvironment
por: Zheng, Run, et al.
Publicado: (2022)

CAR-T Therapies in Solid Tumors: Opportunities and Challenges
por: Guzman, Grace, et al.
Publicado: (2023)

Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges
por: Zhu, Lingling, et al.
Publicado: (2021)

Interactions between tumor-derived proteins and Toll-like receptors
por: Jang, Gun-Young, et al.
Publicado: (2020)

Toll-Like Receptors: Regulators of the Immune Response in the Human Gut
por: Hug, Hubert, et al.
Publicado: (2018)

Toll-like receptors and NOD-like receptors in rheumatic diseases
por: McCormack, William J, et al.
Publicado: (2009)

Toll-like receptor downstream signaling
por: Kawai, Taro, et al.
Publicado: (2005)

Toll-like receptor 4 in atherosclerosis
por: Li, Hongli, et al.
Publicado: (2007)

Toll-like receptors in lupus nephritis
por: Devarapu, Satish Kumar, et al.
Publicado: (2018)

The Role of Toll-Like Receptors in Oncotherapy
por: Liu, Caiqi, et al.
Publicado: (2019)

Toll-like Receptors in Viral Encephalitis
por: Gern, Olivia Luise, et al.
Publicado: (2021)

Toll-like Receptors and Celiac Disease
por: Talipova, Diana, et al.
Publicado: (2022)

Toll-Like Receptors in Angiogenesis
por: Grote, Karsten, et al.
Publicado: (2011)

Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
por: Favere, Kasper, et al.
Publicado: (2021)

Innate Immune Response to Dengue Virus: Toll-like Receptors and Antiviral Response
por: Fernandes-Santos, Caroline, et al.
Publicado: (2022)

Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors
por: Abarca-Merlin, D. M., et al.
Publicado: (2019)

Toll-like receptors and innate immune responses in systemic lupus erythematosus
por: Lafyatis, Robert, et al.
Publicado: (2007)

Toll-Like Receptors and Myocardial Inflammation
por: Feng, Yan, et al.
Publicado: (2011)

The Role of Toll Like Receptors in Pregnancy
por: Amirchaghmaghi, Elham, et al.
Publicado: (2013)

Toll-Like Receptors, Their Ligands, and Atherosclerosis
por: Hodgkinson, Conrad P., et al.
Publicado: (2011)

The Role of Toll-Like Receptors in Osteoclastogenesis
por: Yim, Mijung
Publicado: (2020)

Counting the Toll of Inflammation on Schizophrenia—A Potential Role for Toll-like Receptors
por: Patlola, Saahithh Redddi, et al.
Publicado: (2023)

Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
por: Indini, Alice, et al.
Publicado: (2021)

The application of Toll like receptors for cancer therapy
por: So, Eui Young, et al.
Publicado: (2010)

Toll-like receptors in pathophysiology of liver diseases
por: Kiziltas, Safak
Publicado: (2016)

Toll-like receptor signaling and stages of addiction
por: Crews, Fulton T., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sjbfntqfef7f1he7cjs6jl46or